Detalhe da pesquisa
1.
Genotype-phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome.
Pediatr Nephrol
; 36(9): 2719-2730, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772369
2.
Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative.
Australas J Dermatol
; 62(1): 17-26, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776537
3.
Prevalence, incidence and management of atopic dermatitis in Australian general practice using routinely collected data from MedicineInsight.
Australas J Dermatol
; 61(3): e319-e327, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173859
4.
Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative.
Australas J Dermatol
; 61(1): 9-22, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529493
5.
Atopic dermatitis in adults: An Australian management consensus.
Australas J Dermatol
; 61(1): 23-32, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31372984
6.
Psoriasis and cancer. An Australian/New Zealand narrative.
Australas J Dermatol
; 60(1): 12-18, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29992535
7.
Psoriasis and infection. A clinical practice narrative.
Australas J Dermatol
; 60(2): 91-98, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30079566
8.
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Lancet
; 389(10086): 2287-2303, 2017 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28478972
9.
Nanobody cytokine blockers in psoriasis.
Lancet
; 397(10284): 1523-1524, 2021 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894820
10.
The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
Australas J Dermatol
; 58(3): 166-170, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402434
11.
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Australas J Dermatol
; 57(1): 24-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827200
12.
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
Australas J Dermatol
; 57(3): 167-74, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26033230
13.
Preclinical Alterations in the Serum of COL(IV)A3(-)/(-) Mice as Early Biomarkers of Alport Syndrome.
J Proteome Res
; 14(12): 5202-14, 2015 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26487288
14.
Correction: Secretion of ERP57 is important for extracellular matrix accumulation and progression of renal fibrosis, and is an early sign of disease onset (doi:10.1242/jcs.125088).
J Cell Sci
; 131(13)2018 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973398
15.
Secretion of ERP57 is important for extracellular matrix accumulation and progression of renal fibrosis, and is an early sign of disease onset.
J Cell Sci
; 126(Pt 16): 3649-63, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23781031
16.
Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions.
J Biol Chem
; 288(23): 16738-16746, 2013 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23530036
17.
Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice.
Proteome Sci
; 12(1): 56, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25525413
18.
Antifibrotic, nephroprotective effects of paricalcitol versus calcitriol on top of ACE-inhibitor therapy in the COL4A3 knockout mouse model for progressive renal fibrosis.
Nephrol Dial Transplant
; 29(5): 1012-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24198271
19.
A luminal intermediate cell state maintains long-term prostate homeostasis and contributes to tumorigenesis.
bioRxiv
; 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909551
20.
Immune mechanisms shape the clonal landscape during early progression of prostate cancer.
Dev Cell
; 58(12): 1071-1086.e8, 2023 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148881